Considering oxidative stress and inflammation are involved in the development of CVD in patients with CKD [37], there is a growing attempt to elucidate whether or not the interplay between PF4 and these mechanisms may play a role in CVD in pediatric CKD. This evidence concerns the gene PF4 and chronic kidney disease.